1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatology Drugs Consumption 2015-2025
2.1.2 Dermatology Drugs Consumption CAGR by Region
2.2 Dermatology Drugs Segment by Type
2.2.1 External Use
2.2.2 Oral
2.2.3 Injection
2.3 Dermatology Drugs Consumption by Type
2.3.1 Global Dermatology Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Dermatology Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Dermatology Drugs Sale Price by Type (2015-2020)
2.4 Dermatology Drugs Segment by Application
2.4.1 Psoriasis
2.4.2 Skin Infections
2.4.3 Acne
2.4.4 Dermatitis
2.4.5 Other
2.5 Dermatology Drugs Consumption by Application
2.5.1 Global Dermatology Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Dermatology Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Dermatology Drugs Sale Price by Type (2015-2020)
3 Global Dermatology Drugs by Company
3.1 Global Dermatology Drugs Sales Market Share by Company
3.1.1 Global Dermatology Drugs Sales by Company (2018-2020)
3.1.2 Global Dermatology Drugs Sales Market Share by Company (2018-2020)
3.2 Global Dermatology Drugs Revenue Market Share by Company
3.2.1 Global Dermatology Drugs Revenue by Company (2018-2020)
3.2.2 Global Dermatology Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Dermatology Drugs Sale Price by Company
3.4 Global Dermatology Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Dermatology Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Dermatology Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dermatology Drugs by Regions
4.1 Dermatology Drugs by Regions
4.2 Americas Dermatology Drugs Consumption Growth
4.3 APAC Dermatology Drugs Consumption Growth
4.4 Europe Dermatology Drugs Consumption Growth
4.5 Middle East & Africa Dermatology Drugs Consumption Growth
5 Americas
5.1 Americas Dermatology Drugs Consumption by Countries
5.1.1 Americas Dermatology Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Dermatology Drugs Value by Countries (2015-2020)
5.2 Americas Dermatology Drugs Consumption by Type
5.3 Americas Dermatology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dermatology Drugs Consumption by Regions
6.1.1 APAC Dermatology Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Dermatology Drugs Value by Regions (2015-2020)
6.2 APAC Dermatology Drugs Consumption by Type
6.3 APAC Dermatology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Dermatology Drugs by Countries
7.1.1 Europe Dermatology Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Dermatology Drugs Value by Countries (2015-2020)
7.2 Europe Dermatology Drugs Consumption by Type
7.3 Europe Dermatology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dermatology Drugs by Countries
8.1.1 Middle East & Africa Dermatology Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Dermatology Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Dermatology Drugs Consumption by Type
8.3 Middle East & Africa Dermatology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dermatology Drugs Distributors
10.3 Dermatology Drugs Customer
11 Global Dermatology Drugs Market Forecast
11.1 Global Dermatology Drugs Consumption Forecast (2021-2025)
11.2 Global Dermatology Drugs Forecast by Regions
11.2.1 Global Dermatology Drugs Forecast by Regions (2021-2025)
11.2.2 Global Dermatology Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dermatology Drugs Forecast by Type
11.8 Global Dermatology Drugs Forecast by Application
12 Key Players Analysis
12.1 AbbVie
12.1.1 Company Information
12.1.2 Dermatology Drugs Product Offered
12.1.3 AbbVie Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 LEO Pharma
12.2.1 Company Information
12.2.2 Dermatology Drugs Product Offered
12.2.3 LEO Pharma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 LEO Pharma Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Dermatology Drugs Product Offered
12.3.3 Johnson & Johnson Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Galderma
12.4.1 Company Information
12.4.2 Dermatology Drugs Product Offered
12.4.3 Galderma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Galderma Latest Developments
12.5 Bristol-Myers Squibb
12.5.1 Company Information
12.5.2 Dermatology Drugs Product Offered
12.5.3 Bristol-Myers Squibb Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bristol-Myers Squibb Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Dermatology Drugs Product Offered
12.6.3 Bayer Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Merz Pharma
12.7.1 Company Information
12.7.2 Dermatology Drugs Product Offered
12.7.3 Merz Pharma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merz Pharma Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Dermatology Drugs Product Offered
12.8.3 Novartis Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Bausch Health Companies Inc
12.9.1 Company Information
12.9.2 Dermatology Drugs Product Offered
12.9.3 Bausch Health Companies Inc Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Bausch Health Companies Inc Latest Developments
12.10 Pfizer
12.10.1 Company Information
12.10.2 Dermatology Drugs Product Offered
12.10.3 Pfizer Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer Latest Developments
12.11 GlaxoSmithKline
12.11.1 Company Information
12.11.2 Dermatology Drugs Product Offered
12.11.3 GlaxoSmithKline Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GlaxoSmithKline Latest Developments
13 Research Findings and Conclusion
【免責事項】
https://www.globalresearch.jp/disclaimer